--- title: "SKB Bio falls 6% in Hong Kong trading" type: "News" locale: "en" url: "https://longbridge.com/en/news/306202497.md" description: "SKB Bio fell 6.02% to HK$396.60. Down 11.21% over five sessions." datetime: "2026-11-20T01:57:22.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/306202497.md) - [en](https://longbridge.com/en/news/306202497.md) - [zh-HK](https://longbridge.com/zh-HK/news/306202497.md) generator: "portal-rs" --- # SKB Bio falls 6% in Hong Kong trading SKB Bio (6990.HK) fell more than **6%** in Hong Kong trading, last at **HK$396.60**. The stock is down 11.21% over the past five sessions and sits 29.49% below its 52-week high of HK$562.50. The Hang Seng Index is down 5.02% over the past five sessions and down 12.41% year to date. The biotechnology industry index fell 4.2% over the same period. Based on public media reports. AI-generated; not investment advice. ### Related Stocks - [06990.HK](https://longbridge.com/en/quote/06990.HK.md) ## Related News & Research - [UBS Reaffirms Their Buy Rating on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H (6990)](https://longbridge.com/en/news/298519345.md) - [Sichuan Kelun Biotech Biopharmaceutical (SEHK:6990) Could Be 21% Undervalued After ADC Approval](https://longbridge.com/en/news/299779758.md) - [South Korea prepares market stabilisation funds after KOSPI hits 10-month low](https://longbridge.com/en/news/306391779.md) - [Lenovo Group (LNVGF): New Buy Recommendation for This Technology Giant](https://longbridge.com/en/news/306391832.md) - [CEO & Chairman Of Legion Consortium Sold 32% Of Their Shares](https://longbridge.com/en/news/306378655.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**